ANNOUNCEMENTS:
Congratulations to Drs. Ron Ben Yair (UM), Yifat Merbl (WIS), and their collaborative team on their recent publication in Nature Communications titled, “Golgi organization is regulated by proteasomal degradation.”
This important publication is the result of a binational collaboration between the laboratory of Yifat Merbl of the Weizmann Institute of Science in Rehovot, Israel and the laboratory of Yanzhuang Wang here at the University of Michigan in Ann Arbor, Michigan.
Their paper identified a previously unknown mechanism of degradation occurring at the Golgi apparatus, a hub for intracellular as well as extracellular protein trafficking, that is important for the structural maintenance of this organelle.
Their research shows that targeting this mechanism in multiple myeloma models increases death of these cancerous cells both in cell culture and in-vivo, providing a potential therapeutic approach.
Collaborative Leadership Team
David J. Pinsky, M.D.
J. Griswold & Marjory Hopkins Ruth Professor and Chief, Cardiovascular Medicine
Professor of Molecular and Integrative Physiology
Executive Scholar, A. Alfred Taubman Medical Research Institute
Director, Samuel and Jean Frankel Cardiovascular Center
University of Michigan Health System
Ofer Binah, Ph.D.
Department of Physiology, Biophysics and Systems Biology, Head
Ruth & Bruce Rappaport Faculty of Medicine, Technion Institute of Technology
Avraham A. Levy, Ph.D.
Faculty of Biochemistry, Dean
Department of Plant and Environmental Sciences, The Weizmann Institute of Science
Core Event Faculty Chairs
Omer Berenfeld, Ph.D.
Professor of Internal Medicine and of Biomedical Engineering
Center for Arrhythmia Research
Alon Kahana, MD, Ph.D.
Associate Professor, Ophthalmology and Visual Sciences, Kellogg Eye Center
Member, University of Michigan Comprehensive Cancer Center
Program
Dear Colleagues,
Welcome to the D. Dan and Betty Kahn 6th Annual Scientific Symposium for the Michigan – Israel Partnership for Research and Education. This year’s scientific symposium promises to be a wonderful showcase for scientific advances which improve human health, led by faculty at The Technion Israel Institute of Technology, The Weizmann Institute of Science, and the University of Michigan.
Please join us, as we explore the convergence of biomedicine and bioengineering. We have an exceptional program planned this year with keynote speakers from three world class academic institutions who will present the latest research on topics ranging from engineering molecules, cells and tissues to biomedical and bioengineering impacts on patient lives. Additional topics include new insights into the biology of stem cells and technology advances leading to scientific discoveries.
Creating collaborations between institutions to enhance discovery is the main goal of the partnership. To that end, the Kahn symposium will also feature past partnerships during the “Tackling Biomedical Challenges Through International Research Partnership” session.
Don’t miss the gallery highlighting the past 5 years of the partnership. We’ve had some very energizing scientific symposium sessions as well as some fantastic social events to further solidify the collaborations and ideas developed at the Kahn symposium.
We look forward to a symposium filled with dynamic presentations, thoughtful discussions, new partnerships, and continued advancement of past partnerships toward new discoveries!
In collaboration,
Avraham A. Levy, Ph.D.
Faculty of Biochemistry, Dean
Department of Plant and Environmental Sciences
The Weizmann Institute of Science
Ofer Binah, Ph.D.
Department of Physiology, Biophysics and Systems Biology, Head
Ruth & Bruce Rappaport Faculty of Medicine,
Technion
David J. Pinsky, M.D.
Griswold Ruth M.D. & Margery Hopkins Ruth Professor of Internal Medicine
Professor of Molecular and Integrative Physiology
Founding Scholar – A. Alfred Taubman Medical Research Institute
Chief, Cardiovascular Medicine
Director, Samuel and Jean Frankel Cardiovascular Center